{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T12:15:51Z","timestamp":1783426551143,"version":"3.54.6"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The FAVOR (Comparison of Quantitative Flow Ratio Guided and Angiography Guided Percutaneous Intervention in Patients with Coronary Artery Disease) III China trial demonstrated that percutaneous coronary intervention (PCI) lesion selection using quantitative flow ratio (QFR) measurement, a novel angiography-based approach for estimating fractional flow reserve, improved two-year clinical outcomes compared with standard angiography guidance. This study aimed to assess the cost-effectiveness of QFR-guided PCI from the perspective of the current Chinese healthcare system.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This study is a pre-specified analysis of the FAVOR III China trial, which included 3825 patients randomized between December 25, 2018, and January 19, 2020, from 26 centers in China. Patients with stable or unstable angina pectoris or those \u226572 hours post-myocardial infarction who had at least one lesion with a diameter stenosis between 50% and 90% in a coronary artery with a \u22652.5 mm reference vessel diameter by visual assessment were randomized to a QFR-guided strategy or an angiography-guided strategy with 1:1 ratio. During the two-year follow-up, data were collected on clinical outcomes, quality-adjusted life-years (QALYs), estimated costs of index procedure hospitalization, outpatient cardiovascular medication use, and rehospitalization due to major adverse cardiac and cerebrovascular events (MACCE). The primary analysis calculated the incremental cost-effectiveness ratio (ICER) as the cost per MACCE avoided. An ICER of \u00a510,000\/MACCE event avoided was considered economically attractive in China.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>At two years, the QFR-guided group demonstrated a reduced rate of MACCE compared to the angiography-guided group (10.8% <jats:italic toggle=\"yes\">vs<\/jats:italic>. 14.7%, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt;0.01). Total two-year costs were similar between the groups (\u00a550,803 \u00b1 21,121 <jats:italic toggle=\"yes\">vs<\/jats:italic>. \u00a550,685 \u00b1 23,495, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.87). The ICER for the QFR-guided strategy was \u00a53055 per MACCE avoided, and the probability of QFR being economically attractive was 64% at a willingness-to-pay threshold of \u00a510,000\/MACCE avoided. Sensitivity analysis showed that QFR-guided PCI would become cost-saving if the cost of QFR were below \u00a53682 (current cost: \u00a53800). Cost-utility analysis yielded an ICER of \u00a556,163 per QALY gained, with a 53% probability of being cost-effective at a willingness-to-pay threshold of \u00a585,000 per QALY gained.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>In patients undergoing PCI, a QFR-guided strategy appears economically attractive compared to angiographic guidance from the perspective of the Chinese healthcare system.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial Registration:<\/jats:title>\n            <jats:p>\n                                 ClinicalTrials.gov, NCT03656848.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cm9.0000000000003484","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T05:00:31Z","timestamp":1740978031000},"page":"1186-1193","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Cost-effectiveness of angiographic quantitative flow ratio-guided coronary intervention: A multicenter, randomized, sham-controlled trial"],"prefix":"10.1097","volume":"138","author":[{"given":"Yanyan","family":"Zhao","sequence":"first","affiliation":[{"name":"Medical Research and Biometrics Center, National Center for Cardiovascular Diseases, Beijing 100037, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changdong","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[{"name":"Medical Research and Biometrics Center, National Center for Cardiovascular Diseases, Beijing 100037, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zening","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guosheng","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yundai","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Sixth Medical Center, Chinese PLA General Hospital, Beijing 100048, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Peking University Third Hospital, Beijing 100191, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinkai","family":"Qu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Huadong Hospital Affiliated to Fudan University, Shanghai 200040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaojun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Xuzhou Third People\u2019s Hospital, Xuzhou Medical University, Xuzhou, Jiangsu 221005, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kefei","family":"Dou","sequence":"additional","affiliation":[{"name":"Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjian","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixian","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengxian","family":"Tu","sequence":"additional","affiliation":[{"name":"Biomedical Instrument Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai 200025, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Escaned","sequence":"additional","affiliation":[{"name":"Hospital Cl\u00ednico San Carlos IDISSC, Complutense University of Madrid, Madrid 28040, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William F.","family":"Fearon","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine and Stanford Cardiovascular Institute, Stanford University School of Medicine and VA Palo Alto Health Care System, Palo Alto, CA 94305, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubin","family":"Qiao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Foundation, New York, NY 10019, USA"},{"name":"St. Francis Hospital and Heart Center, Roslyn, NY 11576, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harlan M.","family":"Krumholz","sequence":"additional","affiliation":[{"name":"Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT 06510, USA"},{"name":"Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, CT 06510, USA"},{"name":"Department of Health Policy and Management, Yale School of Public Health, New Haven, CT 06510, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"On behalf of FAVOR III China Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,3,3]]},"reference":[{"key":"R1-20250520","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369\u00a0diseases and injuries in 204 countries and territories, 1990\u20132019: A systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"R2-20250520","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/S0140-6736(15)00057-4","article-title":"Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial","volume":"386","author":"van Nunen","year":"2015","journal-title":"Lancet"},{"key":"R3-20250520","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jacc.2019.10.060","article-title":"Utilization and outcomes of measuring fractional flow reserve in patients with stable ischemic heart disease","volume":"75","author":"Parikh","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R4-20250520","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMoa0807611","article-title":"Fractional flow reserve versus angiography for guiding percutaneous coronary intervention","volume":"360","author":"Tonino","year":"2009","journal-title":"N Engl J Med"},{"key":"R5-20250520","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1205361","article-title":"Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease","volume":"367","author":"De Bruyne","year":"2012","journal-title":"N Engl J Med"},{"key":"R6-20250520","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa1700445","article-title":"Use of the instantaneous wave-free ratio or fractional flow reserve in PCI","volume":"376","author":"Davies","year":"2017","journal-title":"N Engl J Med"},{"key":"R7-20250520","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa1616540","article-title":"Instantaneous wave-free ratio versus fractional flow reserve to guide PCI","volume":"376","author":"G\u00f6tberg","year":"2017","journal-title":"N Engl J Med"},{"key":"R8-20250520","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1161\/CIRCULATIONAHA.117.031907","article-title":"Clinical outcomes and cost-effectiveness of fractional flow reserve-guided percutaneous coronary intervention in patients with stable coronary artery disease: Three-year follow-up of the FAME 2 trial (fractional flow reserve versus angiography for multivessel evaluation)","volume":"137","author":"Fearon","year":"2018","journal-title":"Circulation"},{"key":"R9-20250520","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1161\/CIRCULATIONAHA.113.003059","article-title":"Cost-effectiveness of percutaneous coronary intervention in patients with stable coronary artery disease and abnormal fractional flow reserve","volume":"128","author":"Fearon","year":"2013","journal-title":"Circulation"},{"key":"R10-20250520","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.109.925396","article-title":"Economic evaluation of fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease","volume":"122","author":"Fearon","year":"2010","journal-title":"Circulation"},{"key":"R11-20250520","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.jcin.2016.07.013","article-title":"Diagnostic accuracy of fast computational approaches to derive fractional flow reserve from diagnostic coronary angiography: The international multicenter FAVOR pilot study","volume":"9","author":"Tu","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"R12-20250520","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1016\/j.jacc.2017.10.035","article-title":"Diagnostic accuracy of angiography-based quantitative flow ratio measurements for online assessment of coronary stenosis","volume":"70","author":"Xu","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R13-20250520","doi-asserted-by":"crossref","first-page":"e009603","DOI":"10.1161\/JAHA.118.009603","article-title":"Diagnostic performance of in-procedure angiography-derived quantitative flow reserve compared to pressure-derived fractional flow reserve: The FAVOR II Europe-Japan study","volume":"7","author":"Westra","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"R14-20250520","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ahj.2020.02.015","article-title":"Quantitative flow ratio-guided strategy versus angiography-guided strategy for percutaneous coronary intervention: Rationale and design of the FAVOR III China trial","volume":"223","author":"Song","year":"2020","journal-title":"Am Heart J"},{"key":"R15-20250520","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/S0140-6736(21)02248-0","article-title":"Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): A multicentre, randomised, sham-controlled trial","volume":"398","author":"Xu","year":"2021","journal-title":"Lancet"},{"key":"R16-20250520","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.jacc.2022.09.007","article-title":"2-year outcomes of angiographic quantitative flow ratio-guided coronary interventions","volume":"80","author":"Song","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"R17-20250520","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: A case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"R18-20250520","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: A consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"R19-20250520","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/hec.673","article-title":"Estimating an EQ-5D population value set: The case of Japan","volume":"11","author":"Tsuchiya","year":"2002","journal-title":"Health Econ"},{"key":"R20-20250520","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1161\/01.CIR.0000136821.99814.43","article-title":"Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: Results from the SIRIUS trial","volume":"110","author":"Cohen","year":"2004","journal-title":"Circulation"},{"key":"R21-20250520","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jacc.2006.02.063","article-title":"Cost-effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: Results from the TAXUS-IV trial","volume":"48","author":"Bakhai","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R22-20250520","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.amjcard.2012.05.006","article-title":"Cost-effectiveness of everolimus vs. paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization from the SPIRIT IV trial","volume":"110","author":"Amin","year":"2012","journal-title":"Am J Cardiol"},{"key":"R23-20250520","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.healthpol.2004.03.002","article-title":"Willingness to pay for avoiding coronary restenosis and repeat revascularization: Results from a contingent valuation study","volume":"70","author":"Greenberg","year":"2004","journal-title":"Health Policy"},{"key":"R24-20250520","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10198-021-01384-z","article-title":"Estimation of the cost-effective threshold of a quality-adjusted life year in China based on the value of statistical life","volume":"23","author":"Cai","year":"2022","journal-title":"Eur J Health Econ"},{"key":"R25-20250520","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12962-015-0045-9","article-title":"Fractional flow reserve (FFR) versus angiography in guiding management to optimise outcomes in non-ST segment elevation myocardial infarction (FAMOUS-NSTEMI) developmental trial: Cost-effectiveness using a mixed trial- and model-based methods","volume":"13","author":"Nam","year":"2015","journal-title":"Cost Eff Resour Alloc"},{"key":"R26-20250520","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.amjcard.2005.05.040","article-title":"Thirty-month outcome after fractional flow reserve-guided versus conventional multivessel percutaneous coronary intervention","volume":"96","author":"Wongpraparut","year":"2005","journal-title":"Am J Cardiol"},{"key":"R27-20250520","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ahj.2013.04.007","article-title":"Long-term clinical outcome after fractional flow reserve- versus angio-guided percutaneous coronary intervention in patients with intermediate stenosis of coronary artery bypass grafts","volume":"166","author":"Di Serafino","year":"2013","journal-title":"Am Heart J"},{"key":"R28-20250520","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/j.jacc.2007.01.087","article-title":"Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study","volume":"49","author":"Pijls","year":"2007","journal-title":"J Am Coll Cardiol"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003484","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T12:56:49Z","timestamp":1747745809000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000003484","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,3]]},"assertion":[{"value":"2024-10-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}